help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yip, K. H.M.
Right arrow Articles by Xu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yip, K. H.M.
Right arrow Articles by Xu, J.
(American Journal of Pathology. 2006;169:503-514.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.050960

p62 Ubiquitin Binding-Associated Domain Mediated the Receptor Activator of Nuclear Factor-{kappa}B Ligand-Induced Osteoclast Formation

A New Insight into the Pathogenesis of Paget’s Disease of Bone

Kirk H.M. Yip, Haotian Feng, Nathan J. Pavlos, Ming H. Zheng and Jiake Xu

From the Molecular Orthopaedic Laboratory, School of Surgery and Pathology, University of Western Australia, Nedlands, Australia

Paget’s disease of bone (PDB) is a debilitating bone disorder characterized by giant osteoclasts, enhanced bone destruction, and irregular bone formation. Recently, mutations in SQSTM1 (also known as p62) have been detected in PDB sufferers, with all mutations resulting in either loss of function or truncation/deletion of the ubiquitin binding-associated (UBA) domain. We hypothesized that mutation in the p62 gene resulting in either deletion or premature termination of the UBA domain accounts for the elevated osteoclastic formation and bone resorption associated with PDB. Remarkably, overexpression of the p62 UBA domain deletion mutant (p62{Delta}UBA) significantly enhanced osteoclastogenesis in vitro compared to cells expressing either wild-type p62 (p62WT) or a control vector in a RAW264.7 osteoclastogenic system. Overexpression of p62{Delta}UBA potentiated the formation of abnormally large multinucleated osteoclasts and resorption of bone, reminiscent of PDB. Consistent with the enhancement of osteoclastogenesis, overexpression of p62{Delta}UBA potentiated receptor activator of nuclear factor-{kappa}B ligand-induced activation of nuclear factor-{kappa}B, NFAT, and ERK phosphorylation. Furthermore, as determined by confocal microscopy, deletion of the p62 UBA domain impaired the association of p62 with TRAF6 in the proteasomal compartment. These results suggest that the UBA domain encodes essential regulatory elements required for receptor activator of nuclear factor-{kappa}B ligand-induced osteoclast formation and bone resorption that may be directly associated with the progression of PDB.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Feng, T. Cheng, N. J. Pavlos, K. H. M. Yip, A. Carrello, R. Seeber, K. Eidne, M. H. Zheng, and J. Xu
Cytoplasmic Terminus of Vacuolar Type Proton Pump Accessory Subunit Ac45 Is Required for Proper Interaction with V0 Domain Subunits and Efficient Osteoclastic Bone Resorption
J. Biol. Chem., May 9, 2008; 283(19): 13194 - 13204.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Yan, S. Chen, Y. Zhang, X. Li, Y. Li, X. Wu, J. Yuan, A. G. Robling, R. Karpur, R. J. Chan, et al.
Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1
Hum. Mol. Genet., April 1, 2008; 17(7): 936 - 948.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
M. H. Helfrich, J. C. Crockett, L. J. Hocking, and F. P. Coxon
The Pathogenesis of Osteoclast Diseases: Some Knowns, but Still Many Unknowns
IBMS BoneKEy, February 1, 2007; 4(2): 61 - 77.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.